Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.


  • Content Count

  • Joined

  • Last visited

  • Days Won


Stan1 last won the day on August 23 2019

Stan1 had the most liked content!

Trading Information

  • Vendor
  • Favorite Markets
    US Stocks

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Great info. Would you say the SPX is experiencing a false breakout this week?
  2. This is the key component. If you have a good trading plan, while working when sick isn't advisable, you should still be make the same trades as you would if you weren't sick. Your mental judgement shouldn't be impaired to a degree that you won't follow your plan, if so then yeah, don't work.
  3. Are you trying to tell me I can't get rich just subscribing to someones else's signal?
  4. Great advice, particularly the trading plan. I never see enough of those. If simple is the parameter, then what a simple moving average crossover? Even that is complicated if you can't read a chart. Hmm, buy spy and hold? That seems the most simple. And it is engineered to always go up. Should work.
  5. Well I don't know. Good is only defined by you. What might be good for me might be disastrous for you. What are your goals? How much do you have? These are some of the questions you need to answer. Do you have a trading plan? I might post mine here to help. Most of all, you need to be sure of your own decisions. Asking for what trades are good is a sure way to lose your money. I could tell you what to trade then trade against you and basically just rob you. Learn your own system to trade. Do you have good resources?
  6. Is anyone still trading with Market Profile? It seems such a good system and yet few people use it.
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.